Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Plos One|December 13, 2024
Epidemiology and burden of focal segmental glomerulosclerosis among United States Veterans: An analysis of Veteran's Affairs dataDeborah Goldschmidt, Mark E Bensink, Zheng-Yi Zhou, et al.
The American Journal of Managed Care|July 19, 2018
Treatment patterns among adults with ADHD receiving long-acting therapyZhou Zhou, Zheng-Yi Zhou, Sneha S Kellar, et al.
Clinical Breast Cancer|June 7, 2015
Economic Evaluations of Everolimus Versus Other Hormonal Therapies in the Treatment of HR+/HER2- Advanced Breast Cancer From a US Payer PerspectiveJipan Xie, Yanni Hao, Zheng-Yi Zhou, et al.
Advances in Therapy|April 17, 2016
Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid ArthritisZheng-Yi Zhou, Jenny Griffith, Ella Xiaoyan Du, et al.
Journal of Medical Economics|May 6, 2016
Cost-effectiveness of ceritinib in patients previously treated with crizotinib in anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer in CanadaManjusha Hurry, Zheng-Yi Zhou, Jie Zhang, et al.
Current Medical Research and Opinion|January 9, 2016
An indirect comparison and cost per responder analysis of adalimumab, methotrexate and apremilast in the treatment of methotrexate-naïve patients with psoriatic arthritisKeith A Betts, Jenny Griffith, Alan Friedman, et al.
Kidney Medicine|February 2, 2024
Kidney Failure Attributed to Focal Segmental Glomerulosclerosis: A USRDS Retrospective Cohort Study of Epidemiology, Treatment Modalities, and Economic BurdenMark E Bensink, Deborah Goldschmidt, Zheng-Yi Zhou, et al.
Applied Health Economics and Health Policy|January 4, 2014
Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United StatesHongbo Yang, Paresh Chaudhari, Zheng-Yi Zhou, et al.
Kidney Medicine|January 29, 2024
Kidney Failure Attributed to Immunoglobulin A Nephropathy: A USRDS Retrospective Cohort Study of Epidemiology, Treatment Modalities, and Economic BurdenMark E Bensink, Deborah Goldschmidt, Zheng-Yi Zhou, et al.
Inflammatory Bowel Diseases|March 22, 2023
Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative ColitisXiaoyan Lu, Zheng-Yi Zhou, Yiqiao Xin, et al.
Pageof 6